Acquisition by Safier Jacob of 100000 shares of Orgenesis at 0.6895 subject to Rule 16b-3

ORGSDelisted Stock  USD 1.22  0.31  20.26%   
Slightly above 64% of Orgenesis' investor base is looking to short. The analysis of overall sentiment of trading Orgenesis otc stock suggests that many investors are alarmed at this time. Orgenesis' investing sentiment can be driven by a variety of factors including economic data, Orgenesis' earnings reports, geopolitical events, and overall market trends.
Orgenesis otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Orgenesis daily returns and investor perception about the current price of Orgenesis as well as its diversification or hedging effects on your existing portfolios.
  
Filed transaction by Orgenesis 10 Percent Owner. Grant, award or other acquisition pursuant to Rule 16b-3

Read at macroaxis.com
Acquisition of 100000 common stock (par value $0.01) at 0.6895 of Orgenesis by Safier Jacob on 8th of October 2024. This event was filed by Orgenesis with SEC on 2023-09-21. Statement of changes in beneficial ownership - SEC Form 4

Orgenesis Fundamental Analysis

We analyze Orgenesis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Orgenesis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Orgenesis based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Per Share

Cash Per Share Comparative Analysis

Orgenesis is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Orgenesis Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Orgenesis otc stock to make a market-neutral strategy. Peer analysis of Orgenesis could also be used in its relative valuation, which is a method of valuing Orgenesis by comparing valuation metrics with similar companies.

Peers

Orgenesis Related Equities

INDPIndaptus Therapeutics   5.62   
0%
45.0%
TNGXTango Therapeutics   5.44   
0%
44.0%
DSGNDesign Therapeutics   4.34   
0%
35.0%
RZLTRezolute   3.78   
0%
30.0%
LIXTLixte Biotechnology   3.66   
0%
29.0%
ADAGAdagene   1.99   
0%
16.0%
ACHLAchilles Therapeutics   1.03   
0%
8.0%
ACRVAcrivon Therapeutics,   0.30   
0%
2.0%
ANTXAN2 Therapeutics   0.79   
6.0%
0%
AVTEAerovate Therapeutics   1.17   
9.0%
0%
KTTAPasithea Therapeutics   1.50   
12.0%
0%
QNRXQuoin Pharmaceuticals   12.31   
100.0%
0%
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.
Note that the Orgenesis information on this page should be used as a complementary analysis to other Orgenesis' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Orgenesis OTC Stock

If you are still planning to invest in Orgenesis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Orgenesis' history and understand the potential risks before investing.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities